{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:05:40Z","timestamp":1779555940181,"version":"3.53.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156489","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:04:52Z","timestamp":1776899092000},"page":"156489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["METTL3 promotes the progression of bladder cancer through the METTL3\/IGF2BP3\/MTA1\/PI3K\/AKT axis"],"prefix":"10.1016","volume":"284","author":[{"given":"Dayong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prp.2026.156489_bib1","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Med."},{"issue":"3","key":"10.1016\/j.prp.2026.156489_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","article-title":"Diagnosis and staging of bladder cancer","volume":"35","author":"Ahmadi","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.prp.2026.156489_bib3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a Cancer J. Clinicians"},{"issue":"1","key":"10.1016\/j.prp.2026.156489_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"Chavan","year":"2014","journal-title":"Eur. Urol."},{"issue":"7","key":"10.1016\/j.prp.2026.156489_bib5","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/cas.14927","article-title":"Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer","volume":"112","author":"Chen","year":"2021","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.prp.2026.156489_bib6","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.prp.2026.156489_bib7","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2174\/1570180820666230516160527","article-title":"Vitexin induces apoptosis and ferroptosis and suppresses malignant proliferation and invasion of bladder urothelial carcinoma through PI3K\/AKT-Nrf2 Axis","volume":"21","author":"Chao","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"issue":"12","key":"10.1016\/j.prp.2026.156489_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11934-018-0853-5","article-title":"Molecular characterization of bladder cancer","volume":"19","author":"Chandrasekar","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.prp.2026.156489_bib9","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"12","key":"10.1016\/j.prp.2026.156489_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.urolonc.2018.09.001","article-title":"Post-translational modifications in bladder cancer: Expanding the tumor target repertoire","volume":"38","author":"Oo","year":"2020","journal-title":"Urol. Oncol."},{"issue":"19","key":"10.1016\/j.prp.2026.156489_bib11","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.prp.2026.156489_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040513","article-title":"Epigenetic regulation in exposome-induced tumorigenesis: emerging roles of ncRNAs","volume":"12","author":"Olmedo-Su\u00e1rez","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.prp.2026.156489_bib13","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.prp.2026.156489_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0092-8674(75)90158-0","article-title":"Methylated nucleotides block 5\u2032 terminus of HeLa cell messenger RNA","volume":"4","author":"Wei","year":"1975","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.prp.2026.156489_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"issue":"6409","key":"10.1016\/j.prp.2026.156489_bib16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.prp.2026.156489_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156489_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N(6)-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156489_bib19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156489_bib20","first-page":"65","article-title":"METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy","volume":"42","author":"Sun","year":"2023","journal-title":"J. Experimental Clin. Cancer Res. CR"},{"issue":"3","key":"10.1016\/j.prp.2026.156489_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10585-008-9233-8","article-title":"The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications","volume":"26","author":"Toh","year":"2009","journal-title":"Clin. Exp. Metastas."},{"issue":"9","key":"10.1016\/j.prp.2026.156489_bib22","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/carcin\/bgz200","article-title":"MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK\/ERK\/p90RSK signaling pathway","volume":"41","author":"Nan","year":"2020","journal-title":"Carcinogenesis"},{"issue":"22","key":"10.1016\/j.prp.2026.156489_bib23","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/1759-7714.15007","article-title":"Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p\/MTA1 axis","volume":"14","author":"Wang","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.prp.2026.156489_bib24","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/CMAR.S249979","article-title":"LINC00963 functions as an oncogene in bladder cancer by regulating the miR-766-3p\/MTA1 Axis","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"25","key":"10.1016\/j.prp.2026.156489_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300756","article-title":"MTA1, a Novel ATP synthase complex modulator, enhances colon cancer liver metastasis by driving mitochondrial metabolism reprogramming","volume":"10","author":"Wang","year":"2023","journal-title":"Advanced Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156489_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156489_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.prp.2026.156489_bib28","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1093\/nar\/gky156","article-title":"SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function","volume":"46","author":"Du","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.prp.2026.156489_bib29","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1093\/nar\/gkab378","article-title":"A comprehensive review of m6A\/m6Am RNA methyltransferase structures","volume":"49","author":"Oerum","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.prp.2026.156489_bib30","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","article-title":"JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA","volume":"82","author":"Ni","year":"2022","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2026.156489_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24086905","article-title":"YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3\/YTHDF1-RPN2-PI3K\/AKT\/mTOR Axis","volume":"24","author":"Zhu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156489_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10555-014-9513-5","article-title":"Towards an understanding of the structure and function of MTA1","volume":"33","author":"Millard","year":"2014","journal-title":"Cancer Metastas. Rev."},{"issue":"7","key":"10.1016\/j.prp.2026.156489_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203723666220705152713","article-title":"MTA1: a vital modulator in prostate cancer","volume":"23","author":"Ma","year":"2022","journal-title":"Curr. Protein Pept. Sci."},{"issue":"4","key":"10.1016\/j.prp.2026.156489_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10555-014-9515-3","article-title":"Role of MTA1 in cancer progression and metastasis","volume":"33","author":"Sen","year":"2014","journal-title":"Cancer Metastas. Rev."},{"issue":"1","key":"10.1016\/j.prp.2026.156489_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2019.09.078","article-title":"MTA1 coregulator regulates LDHA expression and function in breast cancer","volume":"520","author":"Guddeti","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2026.156489_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.prp.2026.156489_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","article-title":"M: PI3K\/Akt signalling pathway and cancer","volume":"30","author":"Vara","year":"2004","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.prp.2026.156489_bib38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.prp.2026.156489_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2025.100018","article-title":"Exploring the mechanism of Grifolin in inhibiting the malignant progression of colon cancer cells mediated by the PDGFRB\/PI3K\/AKT signaling pathway based on bioinformatics analysis and network pharmacology","volume":"22","author":"Han","year":"2025","journal-title":"Lett. Drug Des. Discov."},{"issue":"3","key":"10.1016\/j.prp.2026.156489_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1568009611313030003","article-title":"Oxygen-independent regulation of HIF-1: novel involvement of PI3K\/AKT\/mTOR pathway in cancer","volume":"13","author":"Agani","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.prp.2026.156489_bib41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2741\/4443","article-title":"The PI3K\/AKT pathway in the pathogenesis of prostate cancer","volume":"21","author":"Chen","year":"2016","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.prp.2026.156489_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4111\/icu.20240250","article-title":"Dasatinib induces apoptosis and autophagy by suppressing the PI3K\/Akt\/mTOR pathway in bladder cancer cells","volume":"65","author":"Ho","year":"2024","journal-title":"Invest. Clin. Urol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:46:00Z","timestamp":1779554760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S0344033826001421"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156489","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3 promotes the progression of bladder cancer through the METTL3\/IGF2BP3\/MTA1\/PI3K\/AKT axis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156489"}}